SAD Study of APR002 Investigating the Safety/Tolerability, Pharmacokinetics/Pharmacodynamics in Healthy Subjects

NCT05268198 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: APR002
DRUG: Placebo

Sponsor

Global Health Drug Discovery Institute

Collaborators

[object Object]
[object Object]